HopeStage
Back to all studies
Active Not RecruitingNCT04846829

Citalopram or placebo alongside theta-burst stimulation for depression

About this titleRead the official source — NCT04846829
Medication studyAges 21–55United States
The study in practice

Understand this study

Who could participate?

This study is for people with depression. Listed age limits: 21 years to 55 years. Other eligibility criteria apply.

Listed locations
Los AngelesSee all locations and recruitment
Study phase
Early phase 1An early first-in-human or very early safety study, usually focused on how a treatment behaves in the body.

Get this study by email

HopeStage may email me about this study.
Loading the security check...

What to know before participating

A point to clarify

This summary does not cover all risks or eligibility requirements. What risks or changes to my care would apply to me?

Study clarity

Things to check before joining

Study start dateStarted: April 24, 2017
Recruitment status
Active Not Recruiting
Enrollment listed in the registry
30
Sponsor
University of California, Los Angeles
Sponsor type
University
Study type
Drug
Intervention type
Device, Drug
Study phase
Early Phase 1An early first-in-human or very early safety study, usually focused on how a treatment behaves in the body.
Locations
United States
Age range
From 21 Years to 55 Years
Official registry ID
NCT04846829
Official title
Show the full official title

Acute Neurophysiologic Effects of Intravenous (IV) Citalopram Hydrochloride During Transcranial Magnetic Stimulation in Major Depressive Disorder (MDD)

Recruitment & locations

Not recruiting

Los Angeles

Interested in joining this study?

HopeStage may email me about this study.
Loading the security check...
FAQ

Questions about this study

Who is behind this study?

The study sponsor is University of California, Los Angeles, a university.

Does this study involve medication?

Yes. The study involves medication, including Placebo and intravenous citalopram hydrochloride (CIT).

Who can participate?

This study is for people with depression. Listed age limits: 21 years to 55 years. Other eligibility criteria apply.

Is this study still recruiting?

The registry lists this study as active, but no longer recruiting.

Want to explore more studies?

Explore studies